These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 17047036)

  • 41. Melatonin: a rediscovered antitumor hormone? Its relation to surface receptors; sex steroid metabolism, immunologic response, and chronobiologic factors in tumor growth and therapy.
    Regelson W; Pierpaoli W
    Cancer Invest; 1987; 5(4):379-85. PubMed ID: 3311315
    [No Abstract]   [Full Text] [Related]  

  • 42. A Review on Melatonin's Effects in Cancer: Potential Mechanisms.
    Hanikoglu A; Kucuksayan E; Akduman RC; Ozben T
    Anticancer Agents Med Chem; 2018; 18(7):985-992. PubMed ID: 29173185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells.
    Cucina A; Proietti S; D'Anselmi F; Coluccia P; Dinicola S; Frati L; Bizzarri M
    J Pineal Res; 2009 Mar; 46(2):172-80. PubMed ID: 19175854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melatonin and immunomodulation: connections and potential clinical applications.
    Giannoulia-Karantana A; Vlachou A; Polychronopoulou S; Papassotiriou I; Chrousos GP
    Neuroimmunomodulation; 2006; 13(3):133-44. PubMed ID: 17119342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways.
    Ramos S
    Mol Nutr Food Res; 2008 May; 52(5):507-26. PubMed ID: 18435439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
    Raul F
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Melatonin: A new inhibitor agent for cervical cancer treatment.
    Shafabakhsh R; Reiter RJ; Mirzaei H; Teymoordash SN; Asemi Z
    J Cell Physiol; 2019 Dec; 234(12):21670-21682. PubMed ID: 31131897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of melatonin on cytotoxicity of doxorubicin toward selected cell lines (human keratinocytes, lung cancer cell line A-549, laryngeal cancer cell line Hep-2).
    Fic M; Podhorska-Okolow M; Dziegiel P; Gebarowska E; Wysocka T; Drag-Zalesinska M; Zabel M
    In Vivo; 2007; 21(3):513-8. PubMed ID: 17591362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer chemoprevention: a summary of the current evidence.
    Bonovas S; Tsantes A; Drosos T; Sitaras NM
    Anticancer Res; 2008; 28(3B):1857-66. PubMed ID: 18630472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent.
    López-Lázaro M
    Mol Nutr Food Res; 2008 Jun; 52 Suppl 1():S103-27. PubMed ID: 18496811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment.
    Farhood B; Goradel NH; Mortezaee K; Khanlarkhani N; Najafi M; Sahebkar A
    J Cell Physiol; 2019 May; 234(5):5613-5627. PubMed ID: 30238978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation.
    Sanchez-Barcelo EJ; Mediavilla MD; Alonso-Gonzalez C; Reiter RJ
    Expert Opin Investig Drugs; 2012 Jun; 21(6):819-31. PubMed ID: 22500582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of melatonin on melanoma cells subjected to UVA and UVB radiation in In vitro studies.
    Izykowska I; Gebarowska E; Cegielski M; Podhorska-Okolow M; Piotrowska A; Zabel M; Dziegiel P
    In Vivo; 2009; 23(5):733-8. PubMed ID: 19779108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antineoplastic effects of melatonin on a rare malignancy of mesenchymal origin: melatonin receptor-mediated inhibition of signal transduction, linoleic acid metabolism and growth in tissue-isolated human leiomyosarcoma xenografts.
    Dauchy RT; Blask DE; Dauchy EM; Davidson LK; Tirrell PC; Greene MW; Tirrell RP; Hill CR; Sauer LA
    J Pineal Res; 2009 Aug; 47(1):32-42. PubMed ID: 19486272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Melatonin inhibits urethane-induced carcinogenesis tumors in murine lung].
    Vesnushkin GM; Plotnikova NA; Semenchenko AV; Anisimov VN
    Vopr Onkol; 2006; 52(2):164-8. PubMed ID: 17195641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vascular endothelium summary statement III: Cancer prevention and control.
    Reed E; Seffrin J; Giavazzi R; van Hinsbergh V; Madeddu P
    Vascul Pharmacol; 2007 May; 46(5):321-3. PubMed ID: 17234459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Melatonin protects against oxidative stress caused by delta-aminolevulinic acid: implications for cancer reduction.
    Karbownik M; Reiter RJ
    Cancer Invest; 2002; 20(2):276-86. PubMed ID: 11901547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronicles in drug discovery.
    Moral MA; Khurdayan VK; Bozzo J
    Drug News Perspect; 2006 Oct; 19(8):485-9. PubMed ID: 17160149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Basic mechanisms involved in the anti-cancer effects of melatonin.
    Mediavilla MD; Sanchez-Barcelo EJ; Tan DX; Manchester L; Reiter RJ
    Curr Med Chem; 2010; 17(36):4462-81. PubMed ID: 21062257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models.
    Kwon KH; Barve A; Yu S; Huang MT; Kong AN
    Acta Pharmacol Sin; 2007 Sep; 28(9):1409-21. PubMed ID: 17723174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.